Evodiamine attenuates adjuvant ‐induced arthritis in rats by inhibiting synovial inflammation and restoring the Th17/Treg balance

ConclusionsBased on our results, Evo is a promising antiarthritic agent, potentially due to its inhibitory effect on synovial inflammation and regulatory effects on Treg and Th17 differentiation.

Source: Journal of Pharmacy and Pharmacology - February 15, 2020 Category: Drugs & Pharmacology Authors: Hui Zhang, Li Yin, Ming Lu, Jun Wang, Ye ‐tian Li, Wei Lu Gao, Zong‐sheng Yin Tags: Research Paper Source Type: research